Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Two dose regimens of latanoprost compared in glaucoma patients

March 25, 1997

Alphagan receives first European approval

March 25, 1997

Alcon prepares carbonic anhydrase inhibitors

March 13, 1997

Positive phase I results for new formulation of lexipafant

March 12, 1997

Gene linked to juvenile macular degeneration cloned

March 7, 1997

Nonsurgical treatment for vitreous hemorrhage enters clinic in the U.S.

March 6, 1997

Medarex acquires Houston Biotechnology

March 5, 1997

Dorzolamide and timolol alone and in combination for glaucoma

March 4, 1997

AEterna codevelopment agreement for AE-941

Feb. 27, 1997

Bio-Technology General grants license to BioLon in Japan

Feb. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...